Back to Results
First PageMeta Content
Pharmacy / Opinion leadership / Social media / Medicine in China / Medicine / Science / Health / Pharmaceutical industry / Pharmacology


KOL ENGAGEMENT: AUTHORITY AND INFLUENCE IN A DIGITAL WORLD Key opinion leaders have traditionally been the most prestigious names in medicine, valued for their input into a drug’s development, for their validation of t
Add to Reading List

Document Date: 2014-10-01 10:14:36


Open Document

File Size: 1,35 MB

Share Result on Facebook

Company

Novo Nordisk US / Sanofi / M3 Europe Dr Mike Thompson / GlaxoSmithKline / /

Country

United States / /

/

Facility

Campus Sanofi / /

IndustryTerm

broader healthcare organisations / social media / pharmaphorum premium media draws / online followings / social media strategies / thought leadership media / high-value media / healthcare spectrum / social networks / pharmaphorum media / healthcare / pharmaceutical products / external media / healthcare providers / pharma social media / healthcare world / social media engagement / pharmaphorum premium media / engaged web conversations / communications environment / /

MedicalCondition

tumour / diabetes / /

Organization

Portsmouth Hospitals NHS Trust / FDA / /

Person

Astellas Jeremy Boss / Tim Ringrose / Daniel Ghinn / Jeffrey D Bloss / Healthcare Greg Matthews / Mike Thompson / Partha Kar / /

/

Position

haematologist/oncologist and medical director / opinion leader / director of Early Cancer Research at Aurora Health Care / clinical director / diabetes and endocrinology / senior global product manager / CEO / digital opinion leader / managing director / director / MDigitalLife / Executive / Physician / senior vice-president / vice-president / scientific and medical affairs / director / diabetes and endocrinology / leading physician / /

URL

www.pharmaphorum.com/our-services / www.pharmaphorum.com/contribute / www.pharmaphorum.com/premium / www.pharmaphorum.com / /

SocialTag